ARMP Stock-Based Compensation
Armata Pharmaceuticals, Inc. Common Stock · Stock-Based Compensation
ARMP Stock-Based Compensation
Latest reported$5.72Mperiod ending
ARMP TTM Stock-Based Comp ($0.00 → $5.72M)
TTM stock-based compensation
High-resolution chart · PNG
ARMP stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,720,000 | |
| 2,904,000 | |
| 2,610,000 | |
| 2,332,000 | |
| 2,380,000 | |
| 3,140,000 | |
| 2,893,000 | |
| 2,732,000 | |
| 1,689,000 | |
| 615,000 | |
| 938,000 | |
| 1,562,000 | |
| 2,781,000 | |
| 3,469,000 | |
| 3,105,000 | |
| 2,952,000 | |
| 2,575,000 | |
| 2,533,000 | |
| 2,882,000 | |
| 3,080,000 | |
| 3,274,000 | |
| 3,273,000 | |
| 3,475,000 | |
| 3,660,000 | |
| 5,496,000 | |
| 5,216,000 | |
| 4,271,000 | |
| 3,336,000 | |
| 957,000 | |
| 455,000 | |
| 478,000 | |
| 498,000 | |
| 476,000 | |
| 651,000 | |
| 700,000 | |
| 865,000 | |
| 1,101,000 | |
| 1,350,000 | |
| 1,995,000 | |
| 1,928,000 | |
| 1,742,000 | |
| 1,247,000 | |
| 483,000 | |
| 599,000 | |
| 1,514,000 | |
| 1,726,000 | |
| 1,936,000 | |
| 1,821,000 | |
| 1,006,000 | |
| 1,545,000 | |
| 1,437,000 | |
| 1,290,000 | |
| 1,120,000 | |
| 468,000 | |
| 1,032,000 | |
| 948,000 | |
| 870,000 | |
| 912,000 | |
| 1,160,000 | |
| 1,160,000 | |
| 1,160,000 | |
| 1,150,000 | |
| 1,045,000 | |
| 1,045,000 | |
| 1,045,000 | |
| 1,082,000 | |
| 221,000 | |
| 221,000 | |
| 221,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 80,000 | |
| 80,000 | |
| 80,000 | |
| 80,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |